HIGHFDA DEVICE

SeaSpine Orthopedics Recalled 74 Reef TA Inserter Instruments for Reef Interbody System (2025)

SeaSpine Orthopedics recalled 74 Reef TA Inserter instruments used with the Reef Interbody System, distributed worldwide to hospitals and surgical centers. The inserter may cause difficulty disengaging the implant or improper positioning, prolonging surgery and possibly requiring intraoperative revision. Hospitals and surgeons should stop using the device and follow recall instructions from SeaSpn

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
August 6, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 6, 2025
Hazard Level
HIGH
Brand
SeaSpine Orthopedics
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
SeaSpine Orthopedics
Product type
Spine Surgery Inserter Instrument
Model numbers
10889981290733, 10889981437800, BT107376C, BT112289C, BT112779C, BT107376CR1, BT107376CR2, BT107376CR1R2 +2 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 6, 2025

  2. Reported by FDA DEVICE

    September 17, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Inserter, used as part of a system with an intervertebral body fusion device, may contribute to difficulty disengaging the implant or improper implant positioning, which may may lead to prolonged surgery, intraoperative revision, and may require the use of alternate instrumentation. Devices may also have incorrect UDI-DI marking.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact SEASPINE ORTHOPEDICS CORPORATION or your healthcare provider for instructions. Notification method: Letter

About This Product

The Reef Interbody System is a spine fusion device used in surgical procedures. The Reef TA Inserter is an accompanying instrument designed to position the interbody device during surgery.

Why This Is Dangerous

The inserter may cause difficulty disengaging the implant or improper positioning, which can lead to longer surgeries and possible intraoperative revisions. Incorrect UDI-DI markings may complicate device identification and recalls.

Industry Context

This recall is not described as part of a broader industry pattern in the provided data.

Real-World Impact

Hospitals and surgeons must audit instrument kits to ensure only non-recalled devices are used. Delays or revisions can impact operating room schedules and patient recovery timelines.

Practical Guidance

How to identify if yours is affected

  1. Verify Part Number TA2-001003 against inventory lists
  2. Confirm device details with the facility’s sterile processing department or procurement records
  3. Consult the recall notice for additional identifiers and instructions

Where to find product info

UDI-DI markings are on device labels and packaging. Part numbers and model codes are on instrument handles and documentation provided with the Reef Interbody System.

What timeline to expect

Not specified by the manufacturer.

If the manufacturer is unresponsive

  • Document all requests for instructions and dates.
  • Escalate to hospital risk management and the supplier.
  • File a report with the appropriate regulatory body if needed.

How to prevent similar issues

  • Verify UDI-DI and part numbers before use in procedures.
  • Maintain an up-to-date recall audit list for spine implants and instruments.
  • Require recall notifications from vendors before procurement and usage.

Documentation advice

Keep recall letter, FDA notice, device labels, serials, and all correspondence with the manufacturer.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Part Number: TA2-001003 UDI-DI: 10889981290733 and 10889981437800 Other model codes: BT107376C, BT112289C, BT112779C, BT107376CR1, BT107376CR2, BT107376CR1R2, BT112289CR2, BT112779CR2 Quantity recalled: 74 Sold worldwide; US distribution includes NV, TX, ID, MI, OH, SD, TN, PA, CT, CO, FL, WA, NC, OK, MN and Hong Kong Price: Unknown Sold since: Unknown Country of origin: Unknown

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • Part Number TA2-001003
  • Distributed worldwide including specific US states and Hong Kong
  • High hazard level; potential to prolong surgery or require intraoperative revision

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
10889981290733
10889981437800
BT107376C
BT112289C
BT112779C
+5 more
Affected States
ALL
Report Date
September 17, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more